To test the hypothesis that endothelial dysfunction in hyperhomocysteinemia (HHcy) was due to increased levels of nitrotyrosine and matrix metalloproteinase (MMP) activity in response of antagonism of peroxisome proliferator activated receptorα (PPARα), cystathionine β synthase (CBS) -/+ mice were bred, tail tissue was analyzed for genotype by PCR, and tail vein blood was analyzed for homocysteine (Hcy) by spectrofluorometry in 50 male offsprings of 20+3 g at the age of 8 weeks. Mice were separated based on plasma Hcy 4.5+1.5 (+/+, wildtype), and 11.7+3.4
Introduction
Homocysteine (Hcy) is involved in nucleic acid methylation (50) . There are four ways by which hyperhomocysteinemia (HHcy) is developed: 1) by methionine rich protein diet; 2) vitamin b12/folate deficiency; 3) heterozygous/homozygous in cystathione β synthase (CBS) activity and b6 deficiency; and 4) renovascular stenosis and volume retention. Although the treatment of vitamin b12/folate reduced the level of plasma Hcy and ameliorated vascular dysfunction, in part, by conversion to methionine (37) , mechanism of other cause of HHcy was poorly understood. In human, heterozygosity (-/+) in CBS activity was associated with HHcy and increased oxidative stress (8) . In CBS -/+ mice, Hcy induced endothelial dysfunction (11) . Hcy caused vascular disease (20) , including arteriosclerosis (43), endothelial cell desquamation (40), thromboresistance (23) , smooth muscle cell proliferation (44), collagen synthesis (44), oxidation of low-density lipoprotein (16) , increased monocyte adhesion to the vessel wall (21) , platelet aggregation (7), coagulation (33) , blood rheology (25) , and activation of plasminogen and matrix metalloproteinase (MMP) [18] . Hcy decreased endothelial nitric oxide (NO) concentration and promoted the formation of nitrotyrosine in the vessel wall (29) . Hcy induced oxidative stress (2) and activated NFkB (5) . A negative correlation between high Hcy level and peroxisome proliferator activated receptor (PPAR) expression had been suggested (6) . The agonists of PPAR attenuated oxidative stress-mediated vascular dysfunction (12) , and hypertension (34) . In addition, PPAR promoted the synthesis of superoxide dismutase (SOD) and catalase (17) and decreased NADPH oxidase (17) . Although Hcy induced constrictive vascular remodeling and PPAR agonists ameliorated remodeling in vitro (30) , the increased oxidative stress was associated with increased MMP activity (45), and the agonists of PPAR decreased oxidative stress and MMP activity in macrophages (24) . It was unclear whether PPAR ameliorated Hcymediated MMP activation in vivo. We hypothesized that Hcy down-regulated PPARα, thereby causing oxidation of NO to nitrotyrosine with consequent increased activation of MMP. MMPinduced changes in vascular wall structure, in turn, may alter wall stress and hemodynamics. Aortic morphology and In situ MMP activity: Aorta was stained with trichrome and van Gieson for collagen and elastin as described (46). The intima-media thickness was measured by a digital micrometer. To determine total MMP activity in the aortas of CBS -/+ and +/+ mice, in situ zymography was performed as described (46). Briefly, freshly isolated aortic segments were laid onto gelatin-gel preequilibrated with Triton X-100 and incubation buffer. The gels after 18 hours were stain for lytic activity with coomassie blue.
Materials and Methods
Plasma Hcy and urinary protein: Hcy was measured by modification of procedure by
Frantzen et al (13) . Briefly, the plasma was reduced by trace amounts of reduced glutathione. The
Hcy was converted to S-adenosyl-l-homocysteine by incubating the plasma with S-adenosyl-lhomocysteine hydrolase (Sigma Chem Co) and adenosine. The fluorescence of the incubate, Sadenosyl-l-homocysteine (SAH), was measured 422 nm when excited at 320 nm. The free nucleotides do not fluoresce. The adenosine and hydrolase were used in reference buffer. The standards of SAH (Sigma Chem Co) were prepared. Since mouse urine had large quantities of proteins (primary mouse major urinary protein, MUP), and male had much higher urinary MUP than female, to collect the urine, male mice were caged in 24-h metabolic cages for several days of acclimatization to reduce separation effects, prior to hemodynamic measurements. MUP was measured by Bio-Rad dye binding assay.
Hemodynamic measurements:
Mice were anesthetized with tribromoethanol (100 mg/kg i.p.). This drug had minimal effects on cardiovascular function in mice (32) . The aortic blood pressure (BP), heart rate (HR), and systolic and diastolic blood pressure (SBP & DBP)
were measured by a PE-10 catheter in aorta through right common carotid artery (27) . The catheter was connected to a pressure transducer (Micro-Med Co) positioned at the level of heart.
Pulsatile arterial pressure signal was analyzed by a computer using customized software (MicroMed Corp). To determine plasma Hcy and to ensure mouse to mouse variation, 0.5 ml blood was collected from each mouse by the same catheter.
Tissue processing: Under deep anesthesia, the mice were euthanized by arresting heart in diastole by injecting 0.2 ml/100 g body weight (IV) of a 20% KCl solution. Thoracic aorta was dissected. Aortic tissue homogenates were prepared (48). For PPAR measurements, aortic nuclear extracts were prepared (47). Bio-Rad dye binding assay was applied to estimate total protein concentration in the tissue extracts. Sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS-PAGE) was performed with and without the reduction.
PPAR, nitrotyrosine and β β β β-actin: The levels of nitrotyrosine and PPAR were measured by Western blot analysis using mouse monoclonal anti-nitrotyrosine antibody (Upstate Biotechnology) and mouse polyclonal anti-PPAR antibody (CalBiochem). The 10% SDS-PAGE at 20-mA/gel was carried out. The samples were prepared in reducing buffer. PPAR antibody recognized both alpha and gamma isoforms. The specificity of antibodies was established by immunoprecipitating the antigen, prior to loading onto the gel, by antibody conjugated-agarose beads (Upstate Biotechnology Inc, NY). To determine whether total protein loaded onto the gel was identical, β-actin Western blots were performed, using anti-β-actin antibody (Sigma Chem Co.). Alkaline phosphatase conjugated secondary antibody was used as detection system. Bands on blots were scanned by Bio-Rad GS-700 densitometer.
Zymographic analysis of MMP activity:
To determine MMP-2 and -9 activity, the gelatin substrate gel zymography containing 1% gelatin in 8% SDS-PAGE was performed (46).
The aortic tissue homogenates were loaded onto the gel under identical condition of total protein.
The scanned band intensity was normalized by beta actin.
Preparation of homocysteine, acetylcholine, nitroprusside, and ciprofibrate solutions: The concentration of homocysteine was determined by spectrophometric titration with dithio-bis-nitrobenzoate (absorption measured at 412 nm) using ε412 nm of 13,600 M -1 cm -1 (48).
Concentrations of acetylcholine, nitroprusside, and ciprofibrate were based on weight measurements. All dilutions from stock solutions were made prior to the experiment. Buffer was used as vehicle control.
Aortic ring preparation & vascular contractility:
The aortic function was measured as described (29) . The lumen diameter was measured by a micrometer. The wall thickness was measured by putting micrometer edges on both side of the aortic wall. The wall stress was To evaluate the viability of aortic ring, the ring was contracted three times by inducing active muscle tone using 20 mM CaCl2, rinsed and reequilibrated before experiment. To accommodate for different sizes and lengths of different rings, the generated tension in grams was normalized with weight of the tissue in grams (38) . Precontracted rings with CaCl2 were relaxed by endothelial-dependent acetylcholine and endothelial-independent nitroprusside. The optimum dose, an effective concentration, (EC50) was measured by a dose-dependence curve between amplitude of contraction and added concentrations of vasoactive agents. We measured the levels of PPAR, nitrotyrosine, and MMP activity in aortic segments after function measurements and observed similar results before and after.
Statistical analysis:
Values were given as mean+SEM from n=6 in each group.
Differences between groups were evaluated by using ANOVA, followed by the Bonferroni post hoc test (42), focusing on the effects of -/+ CBS (+/+ mice to -/+ mice, indicated by **) and treatment (-/+ mice treated with CF compared with -/+ mice, indicated by *). The p < 0.05 was considered significant. Blood pressure in CBS -/+ mice: Systolic blood pressure was 104+8 mmHg in CBS -/+ mice and 90+2 mmHg in wildtype +/+ mice ( Table I ). The treatment of ciprofibrate in CBS -/+ mice for 12 weeks decreased the systolic blood pressure by 10 mmHg (Table I) .
Results

Genotype
Proteinuresis:
CBS -/+ mice demonstrated an increase in protein excretion in urine as compared with wildtype +/+ mice. The treatment with ciprofibrate decreased the levels of MUP in CBS -/+ mice to control levels (Table I) .
Plasma homocysteine:
The levels of plasma Hcy in CBS -/+ mice did not decrease to the control levels after ciprofibrate treatment (Table I) .
Levels of PPAR:
To determine whether ciprofibrate had classical biological effect, such as lever proliferation, liver weight/body weight ratios were measured. The results suggested reduced liver size in CBS -/+ mice. The treatment with ciprofibrate increased liver weight/body weight ratios (Table I) . Ciprofibrate tended to induce both PPARα and γ (Figure 3 ).
Ciprofibrate inhibits nitrotyrosine generation:
The levels of nitrotyrosine were increased in CBS -/+ mice as compared with wildtype +/+ littermate (p<0.01). Treatment with ciprofibrate inhibited the generation of nitrotyrosine in both the -/+ as well as in wildtype +/+ controls ( Figure 4 ).
Activation of MMP-2 and -9 in -/+ CBS mice:
Zymographic analysis revealed increased MMP-9 activity in CBS mice. The treatment with ciprofibrate inhibited completely the MMP-9
and decreased MMP-2 activity by 50% in -/+ as well as wildtype +/+ control mice ( Figure 5 ).
Improvement of aortic function by ciprofibrate:
Aortic response to acetylcholine was attenuated in CBS -/+ mice as compared with wildtype +/+ mice. The dose-response curves were shifted to left in CBS -/+ mice after ciprofibrate treatment as compared with CBS -/+ mice ( Figure 6 ). These results suggested that the treatment with ciprofibrate improved vascular function in CBS -/+ mice.
Discussion
A linear relationship between systolic blood pressure and plasma levels of Hcy has been suggested in elderly patients (41). Some studies have also linked PPAR to hypertension (1, 10), and suggested that peroxisome proliferator fibrates may improve hemodynamic (34) and renal parameters (14, 15) . We suggested that in the absence of PPAR response, ROS generated by Hcy, in part, induced hypertension by increasing vessel wall stress in CBS -/+ mice. The administration of Hcy in rats increased blood pressure (26) . The changes in blood pressure by
Hcy were independent of amount of Hcy, but dependent on the duration, suggesting structural changes by Hcy (26) . The histological analysis revealed that aortic intima-media was thickened in the CBS -/+ mice as compared to controls (Table I and Figure 1 ). Similar results were obtained by other (9) . The thickening of aortas was associated with increased MMP activity ( Figure 2 ).
Others have shown that ciprofibrate inhibited the synthesis of an extracellular matrix (ECM) component fibrinogen (19) and agonist of PPAR caused regression of intima-media thickness in human (28) . The ECM, particularly elastin (50% of the normal vessel wall), surrounding the vascular smooth muscle cell enhances muscle cell compliance with load. Elastin is a good substrate for MMP-2 and -9 (38) . To reduce vessel wall stress, especially in the absence of endothelial nitric oxide and HHcy, the MMP is activated to dilate the vessel by remodeling and degrading elastin. Because elastin turnover is remarkably lower than collagen (36) , the degraded elastin is replaced by stiffer collagen, and the Hcy induces collagen synthesis (44). Therefore, the vessel wall stress is increased (Table I) . Previously we have quantified the decreased elastin and increased collagen in homocysteinemic aortas (29) . Here we demonstrated increased collagen and decreased elastin in aortas of HHcy mice.
The treatment with peroxisome proliferator decreased lipid profile (35) . A number of studies have demonstrated the levels of Hcy in fasting and loading conditions were not changed after fibrate therapy. In fact, some studies reported a slight increase (3). Here is the paradox:
drugs that repair vascular endothelial function may increase Hcy accumulation. Our results suggested that plasma Hcy levels were not altered by fibrate treatment in CBS -/+ mice (Table I ).
In addition, the levels of PPAR were increased after fibrate treatment (Figure 3 ), suggesting that ciprofibrate induced PPAR expression.
Hcy induced multiorgan damage (26) and increased the MUP in CBS -/+ mice ( Table I ).
The treatment of ciprofibrate reduced the injury response by Hcy (Table I) Limitations: The goal of this study was to test whether the high MMP and nitrotyrosine arterial levels in HHcy animals were secondary to Hcy-induced down-regulation of PPARα. We have shown that CF, a PPARα agonist, increased PPAR expression in HHcy mouse aorta while reducing aortic nitrotyrosine and MMP levels. However, MMP and nitrotyrosine levels were also down regulated by CF in wild-type mice, a phenotype in which CF did not upregulate PPAR expression. We speculated that this phenotype may be due to a threshold level of PPAR in normal mice. It was possible that CF had other effects on vascular muscle perhaps inducing transcription of other enzymes. Indeed, other effects of CF were likely another possible explanation for the observation that CF down-regulated MMP activity and nitrotyrosine levels but not PPAR expression especially in wildtype mice. There was a basal level of nitrotyrosine in aorta of wildtype +/+ mice. However, it was lower than -/+ mice ( Figure 4 ). Similar levels were reported by other (9) . The treatment with ciprofibrate decreased nitrotyrosine levels in CBS -/+ mice. Collectively these studies suggested that Hcy interfere with NO signaling via the cGMP pathway, which may impact remodeling, structure and function in the vessel wall. weeks were prepared. The rings were contracted with 20 mM CaCl2. The % relaxation to acetylcholine was measured based on the total CaCl2 contraction. The acetylcholine doseresponse curves were generated. The lines between % relaxation and acetylcholine dose were
